Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer

Leibowitz-Amit Raya; Templeton Arnoud J.; Alibhai Shabbir M.; Knox Jennifer J.; Sridhar Srikala S.; Tannock Ian F.; Joshua Anthony M.

首页> 外文期刊>Journal of geriatric oncology >Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer

【24h】

Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer

机译：阿比特龙和多西紫杉醇对八岁老人转移性去势抵抗性前列腺癌的疗效和毒性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To assess the efficacy and toxicity of abiraterone and docetaxel in men with metastatic castration-resistant prostate cancer (mCRPC) of age >80 compared to younger men.

机译：目的：评估阿比特龙和多西紫杉醇对男性大于80岁的转移性去势抵抗性前列腺癌（mCRPC）的疗效和毒性。

著录项

来源
《Journal of geriatric oncology》 |2015年第1期|共6页
作者
Leibowitz-Amit Raya; Templeton Arnoud J.; Alibhai Shabbir M.; Knox Jennifer J.; Sridhar Srikala S.; Tannock Ian F.; Joshua Anthony M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Abiraterone; Docetaxel; mCRPC; Octogenarians; Toxicity; Efficacy; Prostate cancer;

机译：阿比特龙;多西他赛;mCRPC;产妇;毒性;功效;前列腺癌;

相似文献

外文文献
中文文献
专利

1. Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer [J] . Leibowitz-Amit Raya, Templeton Arnoud J., Alibhai Shabbir M., Journal of geriatric oncology . 2015,第1期

机译：阿比特龙和多西紫杉醇对八岁老人转移性去势抵抗性前列腺癌的疗效和毒性
2. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [J] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, BMC Cancer . 2019,第1期

机译：AbiraTerone醋酸盐加上泼尼松与Cabazitaxel的疗效和安全性作为后续治疗转移阉割前列腺癌中的后续治疗：结果来自前瞻性观察研究（Capro）
3. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel [J] . Jian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, Frontiers in Pharmacology . 2017,第4期

机译：延迟联合雄激素阻断疗法的有效性预测多西他赛治疗后醋酸阿比特龙治疗转移性去势抵抗的前列腺癌患者的疗效。
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [O] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, 2019

机译：一线多西紫杉醇在转移性去势抵抗性前列腺癌后的后续治疗中醋酸阿比特龙联合泼尼松与卡巴他赛的疗效和安全性：前瞻性观察研究（CAPRO）的结果
7. Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO) [O] . Javier Puente, Aranzazu González-del-Alba, Núria Sala-Gonzalez, 2019

机译：AbiraTerone醋酸盐加上泼尼松与Cabazitaxel的疗效和安全性作为后续治疗转移阉割前列腺癌中的后续治疗：结果来自前瞻性观察研究（Capro）

Efficacy and toxicity of abiraterone and docetaxel in octogenarians with metastatic castration-resistant prostate cancer

摘要

著录项

相似文献

相关主题

期刊订阅